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Background: Multifactor cardiovascular disease is the leading cause of death; beside 
well-known cardiovascular risk factors, several emerging factors such as mental stress, diet 
type, and physical inactivity, have been associated to cardiovascular disease. To date, preventive 
strategies are based on the concept of absolute risk calculated by different algorithms and scoring 
systems. However, in general practice the patient’s data collection represents a critical issue.
Design: A new multipurpose computer-based program has been developed in order to:1) easily 
calculate and compare the absolute cardiovascular risk by the Framingham, Procam, and Progetto 
Cuore algorithms; 2) to design a web-based computerized tool for prospective collection of 
structured data; 3) to support the doctor in the decision-making process for patients at risk 
according to recent international guidelines.
Methods: During a medical consultation the doctor utilizes a common computer connected 
by Internet to a medical server where all the patient’s data and software reside. The program 
evaluates absolute and relative cardiovascular risk factors, personalized patient’s goals, and 
multiparametric trends, monitors critical parameter values, and generates an automated medical 
report.
Results: In a pilot study on 294 patients (47% males; mean age 60 p 12 years [p SD]) the global 
time to collect data at first consultation was 13 p 11 minutes which declined to 8 p 7 minutes 
at the subsequent consultation. In 48.2% of cases the program revealed 2 or more primary risk 
factor parameters outside guideline indications and gave specific clinical suggestions to return 
altered parameters to target values.
Conclusion: The web-based system proposed here may represent a feasible and flexible tool 
for clinical management of patients at risk of cardiovascular disease and for epidemiological 
research.
Keywords: internet, informatics, cardiovascular risk, evidence-based practice, medical 
consultation, decision support, clinical information systems
Introduction
Cardiovascular (CV) disease, and in particular coronary artery disease (CAD), is a multi-
factor syndrome that represents the leading cause of death, accounting for over 15 million 
deaths worldwide each year.1,2 In addition to the well-known nonmodifiable risk factors 
for CV disease, such as sex (ie, male gender), age, and genetic predisposition3 there are 
a number of modifiable factors which could – to some extent – be prevented.4
The major modifiable risk factors for CV disease are smoking, hypertension, 
diabetes, and hypercholesterolemia.1,2
The impact of these factors in the development and worsening of CAD has been 
unequivocally demonstrated by international controlled epidemiologic studies and 
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large pharmaceutical trials.1,2 Over the years, research has 
identified over 200 additional risk factors (eg, bio-humoral, 
lifestyle behaviors, and psychosocial factors) associated with 
CAD,5–13 but what has not yet been extensively investigated is 
the true clinical relevance for the majority of them, especially 
compared with that of conventional factors.
A number of algorithms and scoring systems have been 
developed to calculate absolute risk, ranging from simple-
to-use scores to complicated computer-based algorithms, all 
of which are based, however, on just a few risk parameters. 
A fundamental problem for all risk algorithms is that they 
make significantly different assumptions about the nature of 
mathematical relationships that exist between the individual 
variables.14,15
Physicians often underestimate their patient’s CV risk.16 
Only 13% of primary care physicians are said to use a risk 
chart to assess patient’s risk. In another study it was not 
possible to calculate a CV risk using guidelines for 43% of 
patients because of deficiency of information.17 The likely 
explanations are that very often the risk computation is 
performed after and out of the medical consultation, and the 
recording is paper-based and not computerized. Moreover, 
recent studies have shown that in general practice it has 
not been possible to calculate CV risk in 50% of patients 
because of low levels of information recordings.3 Even for 
well-known CV risk factors (eg, blood pressure), less than 
25% of patients with hypertension have adequate blood 
pressure control due to lack of adherence to international 
guidelines,14 and less than 10% have both blood pressure 
and cholesterol controlled.15,17
The aim of the paper is to present a new computer-based 
program, developed by the National Council Research 
Institute of Clinical Physiology of Pisa, with the following 
goals: 1) to calculate easily and compare the absolute risk 
using the two major risk score algorithms that exist today and 
by using the Italian Progetto Cuore risk chart; 2) to design a 
web-based computerized tool for long-term and prospective 
collection of structured data utilized for developing a reli-
able algorithm able to identify correctly individuals at risk; 
3) to support the doctor in the decision making process for 
patients at risk according to the recent international guidelines 
to improve the care of patients with CAD.
Materials and methods
General aspects of the computer-based 
program
We developed the software VIRC (Valutazione Integrata 
del Rischio Cardiovascolare, ie, Integrated Evaluation 
of Cardiovascular Risk) for use free of charge, without 
commercial license, by the medical community anywhere 
in the world. New users can register with their personal 
identification, medical institution, and title by visiting the 
web server homepage (https://virc.ifc.cnr.it). A personal 
account is generated and communicated via email.
The computer-based program enables physicians to use 
their computer during patient appointments to collect in a 
systematic way the data on the patient’s clinical status.
Development of the project included the following steps: 1) 
definition of dataset; 2) execution of a pilot study on a limited 
series of patients (n  294); 3) territorial extension of the pilot 
study with involvement of 20 practitioners to obtain a relatively 
large sample of patients enrolled (n  3000 in current year); 
4) adjustment of the model data, if necessary, on the basis of 
indications raised by pilot studies; 5) extension of the program 
with enrollment of at least 10,000 patients, a number consid-
ered appropriate for preliminary epidemiological studies, in 
18 months. The first two steps have now been completed and 
step 3 is now in progress in the Tuscan territory. Next year a 
final report is expected on the Tuscany study, and if the results 
are positive, an international trial will be set up.
Dataset
The medical dataset was created by a research group of 
specialists (cardiologists, internal medicine specialists, 
endocrinologists, and others) on the basis of the impor-
tance of each CVD factor as stated in international medi-
cal literature. Two international guidelines were selected: 
1) Pocket guide to prevention of coronary heart disease 
prepared by the International Heart Task Force.14 This is a 
comprehensive guideline based on recommendations by the 
International Arteriosclerosis Society, The American Heart 
Association, The American College of Cardiology, The US 
National Heart Lung and Blood Institute, the Joint European 
Cardiovascular Societies, The World Heart Organization, and 
on the contents of the third report by the Adult Treatment 
Panel of the National Cholesterol Education Program; and 
2) Specific and updated evidence-based guidelines for CV 
disease prevention in women.18
Patient records are stored on a central database server 
together with the application software accessible through 
a firewalled web server. Access to patient data is restricted 
to the physician and, exceptionally, to operators in anony-
mous epidemiological studies; in all other cases access is 
subordinated to explicit patient consent.
The physician, as a client, links to the database server 
using a secure internet protocol by means of a common 
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computer, through a personal account for login and a common 
web browser as software interface, regardless of operating 
system, memory amount, and computer performance. All 
patient data sent on the Internet are coded using a secure 
protocol which safeguards the confidentiality of data trans-
mission to the server. Client–server network layout to enter 
the software and patient’s data is schematically depicted in 
Figure 1.
Structure and function of the system
Dynamic web pages allow the physician to run the software 
and then store, retrieve, compute, and show patient’s data. In 
this way, all data and software are located on the server alone 
and no special client software is needed on the physicians’ 
personal computer. The only requirement for the user is 
to know the server web address and to own a registered 
account. This web architecture permits direct access from 
any location, allowing the server administrator to monitor 
incoming connections. A further operative advantage is 
that updates and changes made to the software on the web 
server are immediately available to all other computers 
simultaneously.
Patient record
Events, diseases, parameters, qualitative data, and even 
diagnosis, indications, and messages are all coded in such 
a way as to better computerize data mining and parameter 
extraction. Table 1 shows the design scheme for patient’s 
record. The data model is tree- structured, creating a user-
friendly interface to record selectively and show patient 
data by means of nested multichoice frames (Figure 2). The 
data detail navigation can be stopped at any level and the 
detail frames and choice types are dynamically shown on 
the basis of the values of current data. This data-oriented 
model facilitates modification and upgrading of data 
without making changes to the software. From such data 
classification, an automatic final medical report may be 
Software
VIRC
Database
Server Internet Client
General 
practitioner
General 
practitioner
Specialist
Specialist
Figure 1 Client–server network layout to enter for software and patient data.
created and, strictly for clinical  purposes, be integrated with 
notes by the physician. The report composition (Figure 3) 
is obtained by referring to a clinical model of the patient 
record (main events, socio-economical factors, family and 
personal history, psychosocial events, physical activity, 
alcohol and dietary habits, atherosclerotic factors, kidney 
function, remote and actual pathologies, surgery interven-
tions and hospitalization, symptoms and clinical signs, 
clinical-basal parameters, blood tests, ongoing therapies, 
referral for diagnostic tests). Other medical speciality areas 
can then be activated by simply integrating and updating 
the database with new patient data. A sharp separation 
exists between the data, structured together with the model, 
and the program, which uses tree-structured frames as a 
general user interface and which supply the engine for 
accessing and processing the data according to the model. 
This method enables the data, and even the model, to be 
upgraded easily and immediately, because the program 
need not be modified and the system can be implemented 
simply in another specialist area, changing only the data 
and the related model.
Program
The software allows the physician to select between first 
consultation and consecutive consultation, which avoids 
rewriting static patient data. Throughout follow-up, the physi-
cian can evaluate the evolution of the patient’s health status 
through charts and trends, estimate changes in risk factors 
over time, evaluate success in risk reduction, and personalize 
policy against risk scores. Figure 4 shows the program 
navigation strategy following the user identification. At the 
first consultation, information on vital statistics, historical 
data, ethnic origin, education, past pathologies, as well as 
static data and social–economic and psychosocial factors, 
are collected by the physician or trained nurse; thereafter, the 
information will be automatically presented by the software 
at each consecutive consultation, with the possibility of if 
being updated. On the other hand, dynamic data, such as 
clinical parameters, actual diseases, therapy, and life-style, 
must be recorded at each consultation. Data and outcome 
estimates can then be printed. Figure 5 summarizes the 
program data flow with the screenshots showing the phases 
of the navigation.
Main events related to CV risk, such as heart attack, 
stroke, and other significant events can be recorded with 
timing of event. Subsequently the software promptly 
informs the physician of the stored event when he or she 
accesses the patient data.
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Table 1 Design scheme for patient record
Personal data Frame First level details
Name, birth date, sex, ethnic origin, country…..
Medical data Socio-economic factors
Study degree Primary, secondary, bachelor,..
Professional activity Employed, unemployed, retired,..
Main job occupation Manual job, intellectual job, driver, manager,..
Family history
Relatives up to 2nd degree CV death/main CV and non-CV diseases and risk factors  
(diabetes, hyperlipidemia.,..)
Personal history
Sleep disorders (trouble to sleep, early wake up,..)
Gynecologic/obstetric diseases (polycystic ovary, pregnancy, diabetes,..)
Psychosocial factors
Adverse life events 6HOIUHSRUWHGSHUVRQDOIDPLO\MREÀQDQFLDOHYHQWVWURXEOHV
Psychological factors Self-reported depression/stress/emotional factors/vitality
Lifestyle
Physical activity Amount/frequency/type (ie, hours per week,..)
Diet Alcohol type (wine, beer, spirit), and amount per day
Mediterranean diet adherence by a validated score
Individual CV risk factors
Primary factors (diabetes, obesity, 
hyperlipidemia, hypertension,..)
Diabetes duration, insulin dependent or noninsulin-dependent diabetes,..
Smoke Type, amount, length (ie, pack-years),..
Preclinic atherosclerosis Left ventricular hypertrophy calcium score, intima media thickness…
Previous diseases Main remote pathologies: gastrointestinal, neurologic, pulmonary,  
uro-genital, vascular diseases,…
Hospitalization Number and type (CV or non-CV) of admission during last year
Surgical/CV procedures Main procedures: District (ie, aorta, coronary, renal), date of intervention…
Actual diseases
CV pathologies Type (ie, angina, ischemic card. dis., stoke), year, detail
Non CV pathologies Type (ie, renal, endocrine, collagen diseases..)
Clinical-chemical parameters
Basic vital signs BP, HR, BMI, waist, hip circumference,..
Bio-humoral tests Date, type and value
CV consultation
Main symptoms and clinical signs Type and detail (ie, chest pain, dyspnea, vascular murmurs,  
declive edema, NYHA class.,…
Ongoing therapies Drug: international nonproprietary name, trade name, dosage
Abbreviations: BP, blood pressure; BMI, body mass index ; CV, cardiovascular; HR, heart rate; NYHA, New York Heart Association.
Nested multiple choice frames aid the physician in 
conducting the physical examination of the patient according 
to standard clinical good practice criteria to establish a stan-
dard model of clinical data description.
Pilot study
We set up a pilot study to define the feasibility and the clinical 
utility of the web-based program, and identify any glitches. To 
do this, we selected five doctors working in different cities of the 
Tuscany region who used computers in their daily practice.
Before starting the pilot study we arbitrarily defined the 
outcome as cut-offs that could be used to define the success 
or not of the pilot study, ie:
 cut-off for recruitment – at least 200 patients in 6 months 
and at least 40 patients for each recruiter
 cut-off for feasibility – glitches 10% during consultation
 average consultation time 20 minutes in 80% of 
consultations
 cut-off for clinical powerful – evidence for at least 2 
concomitant emerging CV risk factors in 30% of 
subjects.
Results
The medical layout and main fields are shown in Figure 6. 
By selecting the button and list icons further details can be 
obtained in subsequent frames.
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Main symptoms and
Clinical signs
Next
Consciousness loss
Chest pain
Dispnonea
Palpitations
Vascular murmurs
Cardiac auscultation
Declive  oedema
Altered peripheral pulse
NO SYMPOTOM/SIGN
Normal
Cardiac auscultation type
Rumours type
Systolic
Diastolic
Location
Mitralic valve
Multi valve
Aortic valve
Added rumours 
rumours 
Figure 2 Example of consequent frames in a multichoice answer used in the patient 
record.
Report of Mrs RL born on 02 February 1945 
Date of consultation on 21 February 2008 at 05:28 pm
Family history: mother: dyslipidemia, ischemic cardiopathy
Smoking habit: 15 cigarettes per day for 10 years 
No physical activity
Diet score: 18 (moderate adherence to mediterranean diet: male>25, female>27)  
Individual CV risk factors: dyslipidemia
Kidney function (Cockroft-Gault) 40.4 mL/min normalized to body surface
Basal parameters: BP 130/70 mmHg, HR 70 bpm, sinus rhythm, weight 77 Kg,
Height 160 cm, BMI 30.1, waist circumference 93 cm, hip circumference 106 cm 
Waist/hip ratio: 0.88 
Blood test (12/02/2008): HDL 40 mg/dL, LDL 170 mg/dl, total cholesterol 250 mg/dl   
Triglycerides 200 mg/dL, creatinine 1 mg/dL, glycemia 85 mg/dL
CV risk at 10 years:
Method     Global    Base 
FRAMINGHAM  19%    5.1%
PROCAM    8.6%    1%
PROGETTO CUORE  5%–10%   <5% 
Objectives:
1)    to increase physical activity at 30 min per day;
2)    to stop smoking;
3)    to reduce BMI to <25 and waist circumference <80 cm;
4)    to balance dietary intake (diet score >27);
5)    to reduce LDL<130 mg/dL and TGL<150 mg/dL 
Figure 3 Example of the program’s indications for a typical patient.
Abbreviations: BP, blood pressure; BMI, body mass index; CV, cardiovascular; 
HDL, high-density lipoprotein; LDL, low-density lipoprotein; TGL, triglycerides.
START
First consultation
Following consultation
Patient’s archive
RETRIEVED PATIENT DATA
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Medical data
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Patient’s goals 
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Medical report
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Figure 4 Navigation strategy.
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Technical system
The software enables the physician to identify the patient’s 
CV state through several computing and referring instru-
ments, as listed below:
 Computed CV risk factor: Framingham, Procam, Progetto 
Cuore indexes19,20,27 are promptly computable to supply abso-
lute, relative, and baseline 10-year CV risk of CV events. The 
software allows changes to one or all of the patient’s modifi-
able parameter values (eg, cholesterol, pressure, smoking) 
to predict the new (ie, relative) CV risk factor (Figure 7).
 The program considers all the algorithms: a) the global 
risk (absolute) related to the different parameters utilized 
for each algorithm; b) the basic risk (baseline) deduced 
from static (ie, sex and age) parameters from the patient 
and by including all the modifiable parameters as normal; 
c) the hypothetic, expected risk (relative) by starting from 
the parameters measured for the patient and by assuming 
the normalization of one or more parameters.
 Patient objectives: Figure 3 shows a typical example of 
data collected for a 63-year-old, smoker, normotensive, 
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hyperlipidemic female, with no physical activity or 
Mediterranean diet. The quantitative values of prescrip-
tions, computed for CV risk target, can be adjusted by 
the physician in agreement with the patient in order to 
establish together a personalized therapeutic path that the 
patient could indeed follow in his or her daily life. 
The effect of patient compliance must be evaluated by 
the physician at the next consultation and, if necessary, 
discussed again.
Figure 7 Example of absolute, baseline and predicted CV risk as computed by the 
program.
Figure 8 Example of agreed and predicted graph (red: measured, green: agreed by 
the doctor, blue: predicted by guidelines).
Figure 6 Synoptic medical layout.
 Multiparametric/agreed and predicted graph/trends. 
Temporal trends of different kinds of the patient’s multiple 
data arising from actual and previous consultations can 
be shown on a table or on a plot underlying the relation-
ships among different parameters. Moreover, each single 
parameter is plotted in a graph as real values recorded 
at consultations together with the target value (obtained 
from guidelines and the value the physician agreed 
with the patient during the objectives definition phase 
(microgoals). This kind of plot allows the physician (and 
the patient) to evaluate the effectiveness of a personalized 
therapeutic path (Figure 8).
 Critical values: To better characterize the patient’s clini-
cal status, the software is able to present evidence for 
all clinical parameters that can be considered critical 
according to international recommendations.14,18,22 The 
software takes into account the comorbidity effects (eg, 
diabetes, hypertension, hyperlipidemia) that change the 
target values derived from single pathology guidelines.14 
This suggestion aims to reduce possible omissions or 
underestimations of the patient data by the physician, 
leaving them free to make their own evaluation.
 Medical report: At the end of the consultation, the struc-
tured data are automatically summarized in natural text 
in a report like the typical medical report, which can be 
stored or printed for further consultation as a unique docu-
ment describing the consultation. The physician might 
change it or update it in free text, which is not computable 
for epidemiological analysis.
Pilot study validation
The main data derived from the pilot study are reported in 
Tables 3–7. Table 2 shows the main demographic data for 
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Table 2 Demographic information about the sample used for 
the pilot study 
GP (n  2) Specialist (n  3) Total
Recruited patients 163 131 294
Male/female 96/67 60/71 294
Age 59 p 10 62 p 15 60 p 12
BMI 27.1 p 4 25.3 p 4 26.2 p 4
Abbreviation: GP, general practitioner.
the sample utilized in the pilot study. Figure 9 depicts the 
geographical distribution of the doctors involved in pilot 
study. A total of 294 patients was recruited in 6 months and 
only 1 out of the 5 doctors did not reach the 40 recruitments 
cut-off (Table 3).
 Feasibility: Global time to collect data at first consultation 
was 13 p 11 minutes which declined to 8 p 7 minutes at 
the subsequent consultation. Of first consultations, 16% 
were more the 20 minutes (Table 4).
 Glitches: Technical glitches, such as trouble entering 
server, were observed in only 2% of cases. Very occa-
sionally doctors were unable to find a suitable choice 
among program proposals (ie, heavy drinking only once 
a week).
 Clinical validation: Table 5 reports the percentage of 
positive primary and additional risk factors in the stud-
ied population. Table 6 reports the difference in CV risk 
estimate by different algorithms according to the sever-
ity of computed risk. In 48.2% of cases (Table 7) the 
program revealed 2 or more parameters out of the main 
guideline indications and gives specific clinical sugges-
tions to return parameters to target values. As shown 
in Table 7, the CV risk factor numbers of the studied 
population are independent from sex and age: more than 
80% had at least 1 CV risk factor and almost half had 
2 CV risk factors. Notably, additional CV risk factors 
(eg, obesity and mental stress) were highly represented 
in the population (Table 5). Also, more than 44% of 
cases/patients showed at least 2 or more additional CV 
risk factors.
Table 3 Consultation statistics for the pilot study
Doctors Patient number
First Subseq. Total
Doct. 1 63 3 66
Doct. 2 21 0 21
Doct. 3 43 0 43
Doct. 4 67 12 79
Doct. 5 100 6 106
Total 294 20 315
Discussion
The management of primary and secondary CV prevention is 
increasingly complex due to i) its intrinsic multidisciplinary 
nature and ii) the rapid growth of pathophysiological knowl-
edge in the field.6,12,14,15,23–25 A well-designed computer based 
program might thus represent a useful tool to assist physicians 
during their daily clinical practice.26 The main advantages 
over the currently available computerized systems to assess 
CV risk19,20,26,27 are the result of the web-based architecture. 
First, no software needs to be installed on the doctor’s com-
puter and the patient data between client and server does not 
need upgrading because all data and software reside on the 
server; only a low download speed internet link is required, 
since the amount of data transferred is very low. Second, all 
patient data on the server are updated at all times, and are 
available worldwide at any time; changes in the program and 
upgrade of guidelines are immediately usable.
In current clinical practice doctors separate the CV risk 
evaluation from the routine consultation, even if they use 
an electronic patient record program; the purpose of the 
proposed program is to combine these two phases to avoid 
data replication.
Table 4 *OREDO WLPH WR FROOHFW GDWD DW ÀUVW DQG VXEVHTXHQW
consultation
Consultation time 
(minutes)
First Subsequent
5 12% 36%
From 5 to 10 37% 29%
From 10 to 15 28% 21%
From 15 to 20 9% 7%
From 20 to 25 4% 0%
From 25 to 30 5% 7%
30 7% 0%
Mean (pSD) 13 ' 11 8 ' 7
Table 5 Percentage of primary and additional cardiovascular 
(CV) risk factors (RF) found in the pilot study
Primary CV RF % male % female
Hypercholesterolemia 62 63
Hypertriglyceridemia 42 26
Hypertension 25 14
Diabetes 9 6
Smoking habit 14 10
Additional RF
Overweight 19 18
Obesity 48 26
No Mediterranean diet 68 86
No physical activity 55 66
Mental stress 38 53
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Table 6 Normalized difference in cardiovascular (CV) risk factor 
computation by different algorithms according to the severity of 
computed risk
CV risk % Framingham Procam Prog. Cuore
5% 26% 55% 54%
5%–10% 25% 12% 22%
10%–15% 19% 6% 15%
15%–20% 9% 5% 4%
20%–25% 6% 4% 3%
25%–30% 3% 5% 2%
30% 11% 13% 2%
A real problem arises when doctors already use their own 
electronic patient record programs. A specific middleware 
should be developed to integrate both databases and even 
a data entry interface so that doctors do not input the same 
data twice.
The major advantages of the computer-based approach 
described here are:
 Simple and usable data acquisition that is as compre-
hensive as possible in terms of both well-known and 
less-known, but emerging, CV risk factors including 
psychosocial and behavioral factors. In particular, the 
new computer program is intended to evaluate a large 
number of parameters instead of the few used to define 
algorithms of the principal formulae (eg, Framingham, 
Procam, Progetto Cuore)19,20,27 to calculate absolute 
and relative CV risk. The proposed web-based CV risk 
assessment program, compared with similar existing CV 
risk assessment tools, also enables additional CV risk 
factors (eg, lifestyle, psychological, stress) and greater 
details on smoking habits to be collected in a structured 
manner.19,20,26,27 The use of a computer program enables 
the doctor to automatically retrieve from the database 
data on the patient’s previous consultation, inputting only 
new values, such as blood pressure values, weight, and 
therefore reducing check-up time. Moreover, adoption of 
hardware/software instruments as data entry by means of 
web forms or optical scanning of typewritten sheet might 
further simplify and speed up program use.
 The program clearly displays and quantif ies the 
comparison between the CV risk indexes of risk measured 
for the patient and those measured for an age- and sex-
matched reference population with indexes accepted as 
normal. Notably, the program can be used during a con-
sultation to allow the patient to immediately understand 
the health benefits predicted with changes in lifestyle (eg, 
stopping smoking or drug abuse, or antihypertensive and/
or lowering lipid treatment). Through the current con-
figuration the program automatically shows both physi-
cian and patient the entity of risk reduction by a specific 
change in one or more of the abnormal risk factors.
 The program is highly flexible in its potential use and 
application. One part can be used for statistical and epi-
demiological purposes (ie, definition of a new chart of CV 
risk for the population under surveillance) and another 
can be used to explore and collect additional clinical data 
to improve patient adherence to therapeutic strategy.28 
It is noteworthy that slightly reducing the weight of risk 
factors can be more beneficial than a greatly reducing a 
single risk factor.14 A target level of risk reduction might 
be achieved by several different routes, and the patient 
could participate in deciding which route to follow. The 
program may also help the doctor to improve personal 
feedback and monitoring of data of interest during treat-
ment by producing graphical trends or tabulations of 
single or multiple parameters over time.
 The program has a substantial component of automated 
checking systems that reduce the risk of diagnostic 
omissions and identif ies critical laboratory values 
according to international guidelines.22 Even more 
Table 7 Percentage of patients with principal cardiovascular (CV) risk factors (ie, blood pressure, low-density lipoprotein cholesterol, 
high-density lipoprotein cholesterol, triglycerides, glycemia, smoke) from the main guideline indications on the basis of the three 
adopted algorithms
Number Male Female
CV risk factors % % cum. Mean age (years) % % cum. Mean age (years)
0 19% 57 17% 60
1 35% 81% 64 32% 83% 61
2 29% 46% 60 23% 51% 58
3 13% 17% 59 16% 27% 63
4 3% 4% 75 10% 11% 58
5 1% 1% 63 1% 1% 67
6 0% 0% 0% 0%
7 0% 0% 0% 0%
Abbreviation: cum., cumulative.
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important is the possibility during a consultation to 
automatically compare the chosen therapeutic program 
with the more reliable guidelines or international 
recommendation in the field. In an era of evidence-
based medicine this represents a fundamental tool to 
convince both doctor and patient of the importance of 
the program.
 Finally three major comments can be made about the 
pilot clinical study:
 a.  The new tool is a feasible and practical way of comput-
ing CV risk in clinical practice within an acceptable 
time frame (Table 4);
 b.  The large variability observed when adopting different 
algorithms to compute CV risk (Table 6) in the same 
subject suggests the need to implement a new, specific 
algorithm for each population under study;
 c.  The high percentage of more than one additional CV 
risk factor (eg, mental stress, obesity, physical activ-
ity) in 44% of patients suggests the need for further 
systematic evaluation of the relative weight of these 
parameters when computing CV risk.
Conclusion
The system we propose represents a feasible and flexible 
tool for clinical management of patients and  epidemiological 
research.
Moreover, the acquisition of structured data enables later 
queries during epidemiological studies. A new algorithm 
based on primary and emerging CV risk factors could be 
provided for the specific population under evaluation after 
collection of a significant amount of patient data by the pres-
ent web-based system. Because the software is server-based, 
upgrades are immediately available to all users.
Summary
v The classical algorithms used for CV risk assessment do 
not take into account several emerging CV risk factors
v Very often, CV risk indexes are computed from different 
populations without considering the specific features of 
the actual population
v Usually, CV risk estimates and electronic medical records 
are separate
v The access from common computers is easy despite 
operating system and application software
v A centralized medical database is available that enables 
the patient to be followed up wherever they are; autho-
rized sharing of patient clinical status between different 
doctors and specialists
v Real time update/upgrades of medical guidelines, patient 
data, and system
v Standardized medical support for patient medical 
consultation
v Personalized therapy and lifestyle changes with patient 
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